Table of Contents Author Guidelines Submit a Manuscript
Multiple Sclerosis International
Volume 2015, Article ID 136295, 10 pages
http://dx.doi.org/10.1155/2015/136295
Research Article

Applying an Open-Source Segmentation Algorithm to Different OCT Devices in Multiple Sclerosis Patients and Healthy Controls: Implications for Clinical Trials

1Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
2Department of Electrical and Computer Engineering, Johns Hopkins University, Baltimore, MD 21287, USA

Received 12 March 2015; Accepted 1 May 2015

Academic Editor: Wolfgang Bruck

Copyright © 2015 Pavan Bhargava et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Compston and A. Coles, “Multiple sclerosis,” The Lancet, vol. 372, no. 9648, pp. 1502–1517, 2008. View at Publisher · View at Google Scholar
  2. D. Toussaint, O. Périer, A. Verstappen, and S. Bervoets, “Clinicopathological study of the visual pathways, eyes, and cerebral hemispheres in 32 cases of disseminated sclerosis,” Journal of Clinical Neuro-Ophthalmology, vol. 3, no. 3, pp. 211–220, 1983. View at Google Scholar
  3. F. Ikuta and H. M. Zimmerman, “Distribution of plaques in seventy autopsy cases of multiple sclerosis in the United States,” Neurology, vol. 26, no. 6, pp. 26–28, 1976. View at Publisher · View at Google Scholar
  4. L. J. Balcer, “Clinical practice. Optic neuritis,” The New England Journal of Medicine, vol. 354, no. 12, pp. 1273–1280, 2006. View at Publisher · View at Google Scholar
  5. B. D. Trapp, J. Peterson, R. M. Ransohoff et al., “Axonal transection in the lesions of multiple sclerosis,” The New England Journal of Medicine, vol. 338, no. 5, pp. 278–285, 2013. View at Google Scholar
  6. M. Calabrese, F. Agosta, F. Rinaldi et al., “Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis,” Archives of Neurology, vol. 66, no. 9, pp. 1144–1150, 2009. View at Publisher · View at Google Scholar
  7. B. Kornek, M. K. Storch, R. Weissert et al., “Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions,” The American Journal of Pathology, vol. 157, no. 1, pp. 267–276, 2000. View at Publisher · View at Google Scholar
  8. R. A. Rudick, S. Mi, and A. W. Sandrock, “LINGO-1 antagonists as therapy for multiple sclerosis: in vitro and in vivo evidence,” Expert Opinion on Biological Therapy, vol. 8, no. 10, pp. 1561–1570, 2008. View at Publisher · View at Google Scholar
  9. B. Wootla, J. O. Watzlawik, A. Denic, and M. Rodriguez, “The road to remyelination in demyelinating diseases: current status and prospects for clinical treatment,” Expert Review of Clinical Immunology, vol. 9, no. 6, pp. 535–549, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Zhornitsky, V. Wee Yong, M. W. Koch et al., “Quetiapine fumarate for the treatment of multiple sclerosis: focus on myelin repair,” CNS Neuroscience & Therapeutics, vol. 19, no. 10, pp. 737–744, 2013. View at Publisher · View at Google Scholar
  11. R. E. Sakai, D. J. Feller, K. M. Galetta, S. L. Galetta, and L. J. Balcer, “Vision in multiple sclerosis: the story, structure-function correlations, and models for neuroprotection,” Journal of Neuro-Ophthalmology, vol. 31, no. 4, pp. 362–373, 2013. View at Publisher · View at Google Scholar
  12. E. M. Frohman, J. G. Fujimoto, T. C. Frohman et al., “Optical coherence tomography: a window into the mechanisms of multiple sclerosis,” Nature Clinical Practice Neurology, vol. 4, no. 12, pp. 664–675, 2008. View at Publisher · View at Google Scholar
  13. D. Huang, E. A. Swanson, C. P. Lin et al., “Optical coherence tomography,” Science, vol. 254, no. 5035, pp. 1178–1181, 1991. View at Publisher · View at Google Scholar
  14. T. C. Chen, “Spectral domain optical coherence tomography: ultra-high speed, ultra-high resolution ophthalmic imaging,” Archives of Ophthalmology, vol. 123, no. 12, pp. 1715–1720, 2005. View at Publisher · View at Google Scholar
  15. S. B. Syc, C. V. Warner, G. S. Hiremath et al., “Reproducibility of high-resolution optical coherence tomography in multiple sclerosis,” Multiple Sclerosis, vol. 16, no. 7, pp. 829–839, 2013. View at Google Scholar
  16. M. Pulicken, E. Gordon-Lipkin, L. J. Balcer, E. Frohman, G. Cutter, and P. A. Calabresi, “Optical coherence tomography and disease subtype in multiple sclerosis,” Neurology, vol. 69, no. 22, pp. 2085–2092, 2007. View at Publisher · View at Google Scholar
  17. J. B. Fisher, D. A. Jacobs, C. E. Markowitz et al., “Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis,” Ophthalmology, vol. 113, no. 2, pp. 324–332, 2006. View at Google Scholar
  18. M. A. Seigo, E. S. Sotirchos, S. Newsome et al., “In vivo assessment of retinal neuronal layers in multiple sclerosis with manual and automated optical coherence tomography segmentation techniques,” Journal of Neurology, vol. 259, no. 10, pp. 2119–2130, 2012. View at Publisher · View at Google Scholar
  19. S. B. Syc, S. Saidha, S. D. Newsome et al., “Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis,” Brain, vol. 135, no. 2, pp. 521–533, 2012. View at Publisher · View at Google Scholar
  20. S. Saidha, S. B. Syc, E. M. Frohman, and P. A. Calabresi, “Reply: primary retinal pathology in multiple sclerosis as detected by optical coherence tomography,” Brain, vol. 134, no. 11, pp. e194–e194, 2011. View at Publisher · View at Google Scholar
  21. A. U. Brandt, T. Oberwahrenbrock, M. Ringelstein et al., “Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography,” Brain, vol. 134, no. 11, article e193, 2011. View at Publisher · View at Google Scholar
  22. S. Saidha, E. S. Sotirchos, J. Oh et al., “Relationships between retinal axonal and neuronal measures and global central nervous system pathology in multiple sclerosis,” JAMA Neurology, vol. 70, no. 1, pp. 34–43, 2013. View at Publisher · View at Google Scholar
  23. S. Saidha, E. S. Sotirchos, M. A. Ibrahim et al., “Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study,” The Lancet Neurology, vol. 11, no. 11, pp. 963–972, 2012. View at Publisher · View at Google Scholar
  24. U. E. K. Wolf-Schnurrbusch, L. Ceklic, C. K. Brinkmann et al., “Macular thickness measurements in healthy eyes using six different optical coherence tomography instruments,” Investigative Ophthalmology & Visual Science, vol. 50, no. 7, pp. 3432–3437, 2009. View at Publisher · View at Google Scholar
  25. C. V. Warner, S. B. Syc, A. M. Stankiewicz et al., “The impact of utilizing different optical coherence tomography devices for clinical purposes and in multiple sclerosis trials,” PLoS ONE, vol. 6, no. 8, Article ID e22947, 2011. View at Publisher · View at Google Scholar
  26. C. H. Polman, S. C. Reingold, B. Banwell et al., “Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria,” Annals of Neurology, vol. 69, no. 2, pp. 292–302, 2011. View at Publisher · View at Google Scholar
  27. A. Lang, A. Carass, M. Hauser et al., “Retinal layer segmentation of macular OCT images using boundary classification,” Biomedical Optics Express, vol. 4, no. 7, pp. 1133–1152, 2013. View at Publisher · View at Google Scholar
  28. L. Breiman, “Random forests,” Machine Learning, vol. 45, no. 1, pp. 5–32, 2001. View at Publisher · View at Google Scholar
  29. K. Li, X. Wu, D. Z. Chen, and M. Sonka, “Optimal surface segmentation in volumetric images—a graph-theoretic approach,” IEEE Transactions on Pattern Analysis and Machine Intelligence, vol. 28, no. 1, pp. 119–134, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Martin Bland and D. Altman, “Statistical methods for assessing agreement between two methods of clinical measurement,” The Lancet, vol. 327, no. 8476, pp. 307–310, 1986. View at Publisher · View at Google Scholar
  31. M. Filippi, J. H. van Waesberghe, M. A. Horsfield et al., “Interscanner variation in brain MRI lesion load measurements in MS: implications for clinical trials,” Neurology, vol. 49, no. 2, pp. 371–377, 1997. View at Publisher · View at Google Scholar · View at Scopus
  32. J. M. Bland and D. G. Altman, “Agreement between methods of measurement with multiple observations per individual,” Journal of Biopharmaceutical Statistics, vol. 17, no. 4, pp. 571–582, 2007. View at Publisher · View at Google Scholar · View at MathSciNet
  33. G. M. Watson, J. L. Keltner, E. K. Chin, D. Harvey, A. Nguyen, and S. S. Park, “Comparison of retinal nerve fiber layer and central macular thickness measurements among five different optical coherence tomography instruments in patients with multiple sclerosis and optic neuritis,” Journal of Neuro-Ophthalmology, vol. 31, no. 2, pp. 110–116, 2011. View at Publisher · View at Google Scholar
  34. F. A. Folgar, E. L. Yuan, S. Farsiu, and C. A. Toth, “Lateral and axial measurement differences between spectral-domain optical coherence tomography systems,” Journal of Biomedical Optics, vol. 19, no. 1, Article ID 016014, 2014. View at Publisher · View at Google Scholar
  35. F. M. Heussen, Y. Ouyang, E. C. McDonnell et al., “Comparison of manually corrected retinal thickness measurements from multiple spectral-domain optical coherence tomography instruments,” British Journal of Ophthalmology, vol. 96, no. 3, pp. 380–385, 2013. View at Publisher · View at Google Scholar